docetaxel anhydrous has been researched along with 4-aminophenyl alpha-d-mannopyranoside in 1 studies
| Studies (docetaxel anhydrous) | Trials (docetaxel anhydrous) | Recent Studies (post-2010) (docetaxel anhydrous) | Studies (4-aminophenyl alpha-d-mannopyranoside) | Trials (4-aminophenyl alpha-d-mannopyranoside) | Recent Studies (post-2010) (4-aminophenyl alpha-d-mannopyranoside) |
|---|---|---|---|---|---|
| 12,110 | 3,216 | 6,920 | 21 | 0 | 10 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jeengar, MK; Khan, W; Singh, I; Sistla, R; Swami, R | 1 |
1 other study(ies) available for docetaxel anhydrous and 4-aminophenyl alpha-d-mannopyranoside
| Article | Year |
|---|---|
p-Aminophenyl-α-D-mannopyranoside engineered lipidic nanoparticles for effective delivery of docetaxel to brain.
Topics: Aniline Compounds; Animals; Antineoplastic Agents; Brain; Cell Line, Tumor; Cell Proliferation; Docetaxel; Dose-Response Relationship, Drug; Drug Delivery Systems; Female; Humans; Lipids; Mannosides; Mice; Nanoparticles; Structure-Activity Relationship; Taxoids; Tissue Distribution | 2015 |